Radioactive cancer drug trial halted after just two patients
Disease control
Terminated
This early-stage study tested a new radioactive drug (225Ac-SSO110) given alongside standard immunotherapy for people with advanced small cell lung cancer or Merkel cell carcinoma. The main goal was to find a safe dose and see if the drug combination showed any early signs of fig…
Phase: PHASE1, PHASE2 • Sponsor: Ariceum Therapeutics GmbH • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC